Kamada Ltd. (KMDA)
USD 5.76
(-1.37%)
USD 5.76
(-1.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 87.74 Million USD | 27.57% |
| 2022 | 68.78 Million USD | 2.02% |
| 2021 | 67.42 Million USD | 60.47% |
| 2020 | 42.01 Million USD | -2.68% |
| 2019 | 43.17 Million USD | 47.27% |
| 2018 | 29.31 Million USD | 39.14% |
| 2017 | 21.07 Million USD | -17.68% |
| 2016 | 25.59 Million USD | -2.82% |
| 2015 | 26.33 Million USD | 3.59% |
| 2014 | 25.42 Million USD | 15.91% |
| 2013 | 21.93 Million USD | 5.84% |
| 2012 | 20.72 Million USD | 34.6% |
| 2011 | 15.39 Million USD | 45.29% |
| 2010 | 10.59 Million USD | 30.25% |
| 2009 | 8.13 Million USD | 0.45% |
| 2008 | 8.09 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 83.58 Million USD | -4.75% |
| 2024 Q2 | 78.46 Million USD | -5.83% |
| 2023 Q2 | 80.23 Million USD | 0.61% |
| 2023 FY | 87.74 Million USD | 27.57% |
| 2023 Q4 | 87.74 Million USD | 18.91% |
| 2023 Q1 | 79.75 Million USD | 15.95% |
| 2023 Q3 | 73.79 Million USD | -8.03% |
| 2022 Q3 | 73.02 Million USD | 13.19% |
| 2022 Q1 | 64.76 Million USD | -3.95% |
| 2022 Q2 | 64.52 Million USD | -0.37% |
| 2022 FY | 68.78 Million USD | 2.02% |
| 2022 Q4 | 68.78 Million USD | -5.81% |
| 2021 Q3 | 48.16 Million USD | 7.99% |
| 2021 Q1 | 41.15 Million USD | -2.05% |
| 2021 FY | 67.42 Million USD | 60.47% |
| 2021 Q2 | 44.6 Million USD | 8.37% |
| 2021 Q4 | 67.42 Million USD | 39.99% |
| 2020 Q3 | 42.61 Million USD | -10.55% |
| 2020 Q2 | 47.64 Million USD | 14.02% |
| 2020 Q1 | 41.78 Million USD | -3.21% |
| 2020 Q4 | 42.01 Million USD | -1.41% |
| 2020 FY | 42.01 Million USD | -2.68% |
| 2019 FY | 43.17 Million USD | 47.27% |
| 2019 Q1 | 31.7 Million USD | 8.16% |
| 2019 Q2 | 35.5 Million USD | 11.96% |
| 2019 Q3 | 34.03 Million USD | -4.14% |
| 2019 Q4 | 43.17 Million USD | 26.86% |
| 2018 Q4 | 29.31 Million USD | 1.32% |
| 2018 FY | 29.31 Million USD | 39.14% |
| 2018 Q3 | 28.93 Million USD | 5.7% |
| 2018 Q2 | 27.37 Million USD | -2.85% |
| 2018 Q1 | 28.17 Million USD | 33.72% |
| 2017 Q3 | 23.14 Million USD | -3.86% |
| 2017 Q2 | 24.07 Million USD | -13.03% |
| 2017 Q1 | 27.67 Million USD | 8.14% |
| 2017 FY | 21.07 Million USD | -17.68% |
| 2017 Q4 | 21.07 Million USD | -8.96% |
| 2016 Q2 | 28.42 Million USD | -10.07% |
| 2016 Q3 | 28.08 Million USD | -1.19% |
| 2016 Q4 | 25.59 Million USD | -8.87% |
| 2016 Q1 | 31.6 Million USD | 20.01% |
| 2016 FY | 25.59 Million USD | -2.82% |
| 2015 Q4 | 26.33 Million USD | -1.77% |
| 2015 Q1 | 27.43 Million USD | 7.91% |
| 2015 Q2 | 24.78 Million USD | -9.66% |
| 2015 FY | 26.33 Million USD | 3.59% |
| 2015 Q3 | 26.81 Million USD | 8.17% |
| 2014 Q3 | 25.54 Million USD | 7.03% |
| 2014 Q1 | 28.61 Million USD | 30.46% |
| 2014 Q2 | 23.87 Million USD | -16.58% |
| 2014 FY | 25.42 Million USD | 15.91% |
| 2014 Q4 | 25.42 Million USD | -0.49% |
| 2013 FY | 21.93 Million USD | 5.84% |
| 2013 Q3 | 22.27 Million USD | -6.79% |
| 2013 Q2 | 23.9 Million USD | 0.67% |
| 2013 Q1 | 23.74 Million USD | 14.58% |
| 2013 Q4 | 21.93 Million USD | -1.55% |
| 2012 FY | 20.72 Million USD | 34.6% |
| 2012 Q3 | 19.04 Million USD | 0.0% |
| 2012 Q4 | 20.72 Million USD | 8.83% |
| 2011 FY | 15.39 Million USD | 45.29% |
| 2010 FY | 10.59 Million USD | 30.25% |
| 2009 FY | 8.13 Million USD | 0.45% |
| 2008 FY | 8.09 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -759.756% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 21.088% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -1196.303% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 15.914% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1430.087% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1430.087% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -4593.225% |
| Alpha Teknova, Inc. | 11.59 Million USD | -656.829% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -171.393% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | -64.659% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | -33.713% |
| Cosmos Health Inc. | 4.78 Million USD | -1732.235% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -10736.181% |
| Embecta Corp. | 152.1 Million USD | 42.31% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -653.385% |
| Procaps Group, S.A. | 96.83 Million USD | 9.383% |
| Theratechnologies Inc. | 6.06 Million USD | -1346.534% |
| Harrow Health, Inc. | 10.86 Million USD | -707.461% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -3127.169% |
| Biofrontera Inc. | 10.9 Million USD | -704.426% |
| DURECT Corporation | 2.21 Million USD | -3854.337% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | -13.356% |
| Cronos Group Inc. | 30.33 Million USD | -189.221% |
| OptiNose, Inc. | 8.05 Million USD | -989.751% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -8774673500.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -1439.678% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -210.575% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -3177.664% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -1803.663% |
| Radius Health, Inc. | 278.64 Million USD | 68.509% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -2524.581% |
| ProPhase Labs, Inc. | 3.84 Million USD | -2184.476% |
| Phibro Animal Health Corporation | 265.91 Million USD | 67.001% |
| Procaps Group S.A. | 96.83 Million USD | 9.383% |
| Alvotech | 74.43 Million USD | -17.887% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 97.471% |
| Rockwell Medical, Inc. | 5.87 Million USD | -1394.579% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -594.584% |
| SIGA Technologies, Inc. | 64.21 Million USD | -36.638% |
| Tilray Brands, Inc. | 252.08 Million USD | 65.192% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -119.482% |
| Shineco, Inc. | 1.58 Million USD | -5423.787% |
| PetIQ, Inc. | 159.3 Million USD | 44.92% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 57534.144% |
| Incannex Healthcare Limited | -10.01 Million USD | 976.153% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -129.104% |
| Alimera Sciences, Inc. | 1.87 Million USD | -4569.864% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -132.836% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -5348.785% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -1857.322% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -34398.151% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -745.344% |
| Hempacco Co., Inc. | 2.54 Million USD | -3351.025% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | -17.887% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -83.594% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -37.042% |
| Currenc Group, Inc. | 732.91 Thousand USD | -11872.359% |
| Indivior PLC | 141.79 Million USD | 38.119% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -18110.762% |
| Flora Growth Corp. | 8.5 Million USD | -931.344% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -34398.151% |
| Evolus, Inc. | 10.99 Million USD | -697.843% |
| HUTCHMED (China) Limited | 50.25 Million USD | -74.593% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 17.089% |
| Akanda Corp. | 1.28 Million USD | -6718.49% |